|1.||Mendoza-Guevara, L: 1 article (01/2007)|
|2.||Castro-Vazquez, F: 1 article (01/2007)|
|3.||Sanchez-Barbosa, J L: 1 article (01/2007)|
|4.||Aguilar-Kitsu, A: 1 article (01/2007)|
|5.||Morales-Nava, A: 1 article (01/2007)|
|6.||Rodriguez-Leyva, F: 1 article (01/2007)|
|7.||Adragna, Marta: 1 article (01/2005)|
|8.||Sojo, Ernesto T: 1 article (01/2005)|
|9.||Agostini, Silvana: 1 article (01/2005)|
|10.||Hernandez, Maria G: 1 article (01/2005)|
01/01/2007 - "In conclusion, Amuchina 10% solution is effective in preventing infection on the exit-site, without any secondary topical reaction."
01/01/2005 - "3% Amuchina is as effective as the 50% concentration in the prevention of exit-site infection in children on chronic peritoneal dialysis."
01/01/2007 - "Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program."
01/01/2007 - "We had nine infections in the soap group and none in the Amuchina 10% solution group, with an OR: 17 (p = 0.004). "
01/01/2005 - "In a previous communication, we demonstrated that, in the prevention of exit-site infection (ESI) in children, the cleansing agent 50% Amuchina (electrolytic chloroxidizer. "
|2.||Chronic Kidney Failure (Chronic Renal Failure)
01/01/1990 - "A protocol of patient selection and more frequent home visits have significantly reduced peritonitis episodes in CAPD patients using Y-set with Amuchina. "
01/01/1989 - "Sixty-one new continuous ambulatory peritoneal dialysis (CAPD) patients were allocated to a Y connector-disinfectant (Amuchina, Italy) and 63 to standard systems (Baxter Systems II & III) in a randomized clinical trial addressing peritonitis rates in 8 CAPD programs in 6 Canadian cities. "
01/01/1991 - "The present paper reports the results of clinical and laboratory tests carried out on two homogeneous groups of ten burn patients subjected to local therapy, either with isotonic chloroxidating solution Amuchina* or with 1% silver sulfadiazine cream at the Burns Centre of the Pisa University Dermatological Clinic. "
|2.||Silver Sulfadiazine (SSD)
|2.||Continuous Ambulatory Peritoneal Dialysis (CAPD)